analysisWe need to parse the provided statement. Determine sample type, malignancy, Gleason. The statement: "Näytteet ovat tyypilliseen tapaan käsiteltyjä prostatan kudosnäytteitä, näytetyypille rutiisti käsiteltynä." Means the samples are prostate tissue samples, routine processed. "Näytteet jaettiin neljään osaan" etc. Sample 1 is inadequate, samples 2 and 3 normal benign. Sample 4 shows cell architecture deviating from normal. There's uncertainty whether it's malignant. They need to confirm. No Gleason reported. So we likely cannot say malignancy for sure. According to guidelines, only if malignant findings present. Here we have uncertain. Should we set Malignancy: "ei" or "NA"? The guidelines say: "Olikko näytteessä pahanlaatuisia löydöksiä (sallitut arvot "kyllä", "ei" tai "NA")." If ambiguous or not specified, maybe "NA". Sample type: It's a routine processed tissue sample, likely "RP" (radical prostatectomy) or "biopsy"? The description: "Näytteet ovat tyypilliseen tapaan käsiteltyjä prostatan kudosnäytteitä, näytetyypille rutiisti käsiteltynä." Could be "biopsy" or "RP". It says "rutiisti käsiteltynä", not specifying surgical removal. Usually "biopsy" is a sampling. I think "biopsy". But "RP" is radical prostatectomy. They didn't say removal. So "biopsy". Malignancy: uncertain. So "NA". Gleason: NA.

Thus output JSON: Sampletype "biopsy", Malignancy "NA", Gleason "NA".assistantfinal```json
{
  "Sampletype": "biopsy",
  "Malignancy": "NA",
  "Gleason": "NA"
}
```